BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 4149412)

  • 41. [Species differences in drug metabolism - overview from animals to man (author's transl)].
    Kato R
    Jikken Dobutsu; 1981 Oct; 30(4):507-17. PubMed ID: 7318948
    [No Abstract]   [Full Text] [Related]  

  • 42. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Enzyme induction in the liver changes drug activity].
    Greim H
    Med Klin; 1980 Sep; 75(20):709-12. PubMed ID: 6999314
    [No Abstract]   [Full Text] [Related]  

  • 45. Nuclear drug metabolism: its ontogeny in the rat and its presence in human fetal life.
    Romano M; Tursi F; Assael BM; Buscaglia M; Dell'Agnola CA; Salmona M
    Prog Clin Biol Res; 1983; 135():395-400. PubMed ID: 6665014
    [No Abstract]   [Full Text] [Related]  

  • 46. Involvement of radical species in the oxidation of aminopyrine and 4-aminoantipyrine by cumene hydroperoxide in rat liver microsomes.
    Ashley PL; Griffin BW
    Mol Pharmacol; 1981 Jan; 19(1):146-52. PubMed ID: 7207458
    [No Abstract]   [Full Text] [Related]  

  • 47. Polymorphic drug oxidation in humans.
    Eichelbaum M
    Fed Proc; 1984 May; 43(8):2298-302. PubMed ID: 6714436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of tobacco smoking on drug metabolism].
    Stańkowska-Chomicz A
    Pol Tyg Lek; 1982 Jul; 37(23):689-91. PubMed ID: 7177964
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmacokinetics of drugs in the elderly].
    Petrin A
    Int J Clin Pharmacol; 1974 Mar; 9(2):157-9. PubMed ID: 4133294
    [No Abstract]   [Full Text] [Related]  

  • 50. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
    Sawada Y; Hanano M; Sugiyama Y; Iga T
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [P-450 cytochrome. Detoxication by liver microsomes].
    Gajdos A
    Nouv Presse Med; 1972 Jun; 1(23):1587-92. PubMed ID: 4402521
    [No Abstract]   [Full Text] [Related]  

  • 52. Antipyrine half-life and drug elimination.
    Breckenridge A
    Clin Pharmacokinet; 1980; 5(3):201-3. PubMed ID: 7389234
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative study of 1-naphthol oxidation by cytochrome P-450 and oxyhemoglobin].
    Metelitsa DI; Popova EM
    Biokhimiia; 1980 Aug; 45(8):1379-84. PubMed ID: 7236790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The metabolic clearance rate of antipyrine: a good index for the assessment of the hepatic drug-oxidizing function in cirrhotic patients (author's transl)].
    Miguet JP; Allemand H; Joanne C; Dhumeaux D
    Nouv Presse Med; 1978 Dec; 7(46):4209-11. PubMed ID: 745958
    [No Abstract]   [Full Text] [Related]  

  • 55. Application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man [proceedings].
    Idle JR; Sloan TP; Smith RL; Wakile LA
    Br J Pharmacol; 1979 Jul; 66(3):430P-431P. PubMed ID: 526719
    [No Abstract]   [Full Text] [Related]  

  • 56. [Sexual variations in the metabolism of antipyrine in vivo and in vitro].
    Salvá P; Salvá JA; Laporte J
    Arch Farmacol Toxicol; 1978 Apr; 4(1):116-9. PubMed ID: 697376
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies on the combination of drugs. IV. Effect of 4-hydroxyantipyrine and N-acetyl-p-aminophenol on the metabolism of phenylbutazone, oxyphenbutazone and ketophenylbutazone].
    Niwa H; Nakayama T
    Yakugaku Zasshi; 1968 Jul; 88(7):838-42. PubMed ID: 5750523
    [No Abstract]   [Full Text] [Related]  

  • 58. Dose-dependent pharmacokinetics: emphasis on phase I metabolism.
    Dayton PG; Sanders JE
    Drug Metab Rev; 1983; 14(3):347-405. PubMed ID: 6347591
    [No Abstract]   [Full Text] [Related]  

  • 59. A new polymorphism of hepatic drug oxidation in man: family studies on rates of formation of antipyrine metabolites.
    Vessell ES; Penno MB
    Biochem Soc Trans; 1984 Feb; 12(1):74-8. PubMed ID: 6705993
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug metabolism in epileptics: in vivo and in vitro correlations.
    Sotaniemi EA; Pelkonen RO; Ahokas J; Pirttiaho HI; Ahlqvist J
    Br J Clin Pharmacol; 1978 Jan; 5(1):71-6. PubMed ID: 619937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.